www.hiv-persistence.com Open in urlscan Pro
31.170.8.39  Public Scan

Submitted URL: http://stats.overcome.fr/c6.php?ec=2&l=h4KPu4Soi29sj5dr&i=ZGRpl2aXY21o&t=ZA&e=pqGf2HDGmaxgns6fldVgndQ&u=m6iq1KOdYGaqp9xgm...
Effective URL: https://www.hiv-persistence.com/about
Submission: On August 20 via api from FR — Scanned from FR

Form analysis 1 forms found in the DOM

POST #sbscrbr-form

<form id="sbscrbr-form" method="post" action="#sbscrbr-form" class="subscrbr-sign-up-form">
  <p class="sbscrbr-email-wrap">
    <input type="text" name="sbscrbr_email" value="" placeholder="E-mail">
  </p>
  <p class="sbscrbr-unsubscribe-wrap">
    <label>
      <input id="sbscrbr-checkbox" type="checkbox" name="sbscrbr_unsubscribe" value="yes" style="vertical-align: middle;"> unsubscribe</label>
  </p>
  <p class="sbscrbr-submit-block" style="position: relative;">
    <input type="submit" value="Subscribe" name="sbscrbr_submit_email" class="submit">
    <input type="hidden" value="sbscrbr_shortcode_1" name="sbscrbr_form_id">
  </p>
</form>

Text Content

Skip to content

HIV Persistence during therapy
International Workshop Miami


 * Home
 * Workshop Information
   * About
   * Press
   * Past editions
 * Committees
 * Program
   * PROGRAM SUMMARY
   * FINAL PROGRAM 2022
 * Abstracts
 * Registration
 * GENERAL INFORMATION
 * Corporate support



 * Home
 * Workshop Information
   * About
   * Press
   * Past editions
 * Committees
 * Program
   * PROGRAM SUMMARY
   * FINAL PROGRAM 2022
 * Abstracts
 * Registration
 * GENERAL INFORMATION
 * Corporate support



December 2015 
Three Hundred Scientists Meet in Miami to Work on a HIV Cure

January 20, 2015 
New anti HIV Drug Dolutegravir is Effective at Low Doses and in the Search for a
HIV Cure

05 August 2014 
General Hospital Reveals Fourteen Years of HIV Functional Cure: The Case of the
‘Toulon Patient’

04 July 2014 
New Approaches Towards HIV Cure to be Tested in Protocol Zero

29 June 2014 
Seventh HIV Persistence Workshop: Researchers United Towards HIV Cure And
Reservoirs Eradication


ABOUT



The International Workshop on HIV Persistence during Therapy is, historically,
the first meeting centered on HIV reservoirs. In 2003, a group of researchers
understood the need for a regular meeting focused on new findings from basic to
clinical science on the persistence of HIV.

HIV reservoirs were only described at the end of 1997 and it was clear that they
were the main obstacles toward HIV eradication. At that time it was not a
research priority and most groups were rather interested by the management of
cART side effects.

However, in 2005, during the second edition of the workshop, the first results
of a clinical trial using HDAC inhibitors to reverse latency within the HIV
reservoir were presented.

In 2009, during the fourth edition, attendees were presented with a case of
a Berlin patient who fuelled hope in the field of an HIV cure.

Mechanisms of HIV persistence and new strategies toward HIV eradication became
the high priority for research agencies and governments. Since its start, the
HIV Persistence during Therapy Workshop has welcomed the main leaders in this
challenging field who have shared their cutting edge work in oral or poster
presentation form with the support of NIH, ANRS, and other organizations.

Growing from 90 participants in 2003 to over 400 participants in 2022, it is
recognized as the reference workshop on HIV reservoirs and cure by the
scientific community.

The members of the Steering and Scientific Committees are well renowned
scientists publishing regularly in high impact journals.

Over four days, the workshop covers basic to clinical science, virologic,
immunologic and pharmacologic aspects of HIV persistence, and is attended by
basic science researchers, virologists, immunologists and clinicians. Broad
participation enables important exchanges between diverse workers in the field.
The workshop seeks to involve others outside HIV research that contribute to
future advances.

The HIV Persistence during Therapy Workshop is dedicated to progress towards the
end of the HIV pandemic.

Newsletter

unsubscribe



By providing us with your email, you agree to receive the HIV Persistence
newsletter and confirm that you have read and understood our privacy policy
available here. You can unsubscribe at any time by clicking the unsubscribe link
at the bottom of our emails or by contacting us at rgpd@overcome.fr

Organization


13-15 rue des Sablons
75116 Paris – France
Phone:+33 (0)1 40 88 97 97,
Email: hivpersistence@overcome.fr

© 2018 - 2022 HIV Persistence. All Rights Reserved - Legal Information.



Go to Top
We use cookies on our website to give you the most relevant experience by
remembering your preferences and repeat visits. By clicking “Accept All”, you
consent to the use of ALL the cookies.

Accept AllReject All
Manage consent
Close

PRIVACY OVERVIEW

This website uses cookies to improve your experience while you navigate through
the website. Out of these, the cookies that are categorized as necessary are
stored on your browser as they are essential for the working of basic
functionalities of the ...
Necessary
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly.
These cookies ensure basic functionalities and security features of the website,
anonymously.

CookieDurationDescriptioncookielawinfo-checkbox-analytics11 monthsThis cookie is
set by GDPR Cookie Consent plugin. The cookie is used to store the user consent
for the cookies in the category "Analytics".cookielawinfo-checkbox-functional11
monthsThe cookie is set by GDPR cookie consent to record the user consent for
the cookies in the category "Functional".cookielawinfo-checkbox-necessary11
monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to
store the user consent for the cookies in the category
"Necessary".cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR
Cookie Consent plugin. The cookie is used to store the user consent for the
cookies in the category "Other.cookielawinfo-checkbox-performance11 monthsThis
cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the
user consent for the cookies in the category
"Performance".viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie
Consent plugin and is used to store whether or not user has consented to the use
of cookies. It does not store any personal data.

Functional
Functional
Functional cookies help to perform certain functionalities like sharing the
content of the website on social media platforms, collect feedbacks, and other
third-party features.
Performance
Performance
Performance cookies are used to understand and analyze the key performance
indexes of the website which helps in delivering a better user experience for
the visitors.
Analytics
Analytics
Analytical cookies are used to understand how visitors interact with the
website. These cookies help provide information on metrics the number of
visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and
marketing campaigns. These cookies track visitors across websites and collect
information to provide customized ads.
Others
Others
Other uncategorized cookies are those that are being analyzed and have not been
classified into a category as yet.
SAVE & ACCEPT